CSIMarket
 

Septerna Inc   (NASDAQ: SEPN)

Septerna Inc 's

Competitiveness




 

SEPN Sales vs. its Competitors Q2 2026







Revenue Growth Comparisons




Net Income Comparison




<<  SEPN Stock Performance Comparisons


Septerna Inc 's Comment on Competition and Industry Peers


The company has a partnership with Novo Nordisk A/S ("Novo") that includes potential milestone payments, royalty payments from commercial product sales, and tiered royalties based on global net sales. Novo's capacity to develop and commercialize potential oral products is a relevant factor in the competitive landscape. Novo Nordisk A/S is identified as a competitor in the company's filings.



*Market share is calculated based on total revenue.





Publicly Traded Peers of Septerna Inc



Sources: Septerna Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Septerna Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.